Dupilumab in papuloerythroderma of Ofuji: therapeutic efficacy and paradoxical flares in a case-based review

Papuloerythroderma of Ofuji (PEO) is a rare disorder characterized by the 'deck-chair sign' and is diagnosed according to the criteria proposed by Torchia et al. in 2009. This study aims to summarize the clinical manifestations, emerging treatments, and prognosis of PEO, and to explore the...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The Journal of dermatological treatment Ročník 36; číslo 1; s. 2562300
Hlavní autoři:	Liu, Teng, Zhang, Meixi, Gao, Xiaoman, Yang, Kun, Bao, Yingqiu, Zhang, Qiuli, Chang, Jianmin
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Taylor & Francis Group 01.12.2025
Témata:	Aged Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - adverse effects Antibodies, Monoclonal, Humanized - therapeutic use Dermatitis, Exfoliative - diagnosis Dermatitis, Exfoliative - drug therapy Dermatologic Agents - administration & dosage Dermatologic Agents - adverse effects Dermatologic Agents - therapeutic use dupilumab Female Humans Male Middle Aged Papuloerythroderma of Ofuji Symptom Flare Up treatment Treatment Outcome tripterygium glycosides treatment tripterygium glycosides Papuloerythroderma of Ofuji dupilumab
ISSN:	0954-6634, 1471-1753, 1471-1753
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!